JPY 873.0
(0.46%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 470 Million JPY | 440.23% |
2022 | 87 Million JPY | -72.47% |
2021 | 316 Million JPY | -44.95% |
2020 | 574 Million JPY | 399.13% |
2019 | 115 Million JPY | -39.47% |
2018 | 190 Million JPY | 27.52% |
2017 | 149 Million JPY | -78.95% |
2016 | 708 Million JPY | 36.15% |
2015 | 520 Million JPY | 26.52% |
2014 | 410.99 Million JPY | -32.65% |
2013 | 610.27 Million JPY | 5.55% |
2012 | 578.19 Million JPY | 2.44% |
2011 | 564.42 Million JPY | 0.0% |
2010 | - JPY | -100.0% |
2009 | 337.46 Million JPY | 149.46% |
2008 | 135.27 Million JPY | -69.78% |
2007 | 447.59 Million JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 104 Million JPY | 2180.0% |
2023 FY | 470 Million JPY | 440.23% |
2023 Q3 | 147 Million JPY | -37.45% |
2023 Q2 | 235 Million JPY | 152.69% |
2023 Q4 | -5 Million JPY | -103.4% |
2023 Q1 | 93 Million JPY | 180.17% |
2022 Q1 | 30 Million JPY | -38.78% |
2022 FY | 87 Million JPY | -72.47% |
2022 Q4 | -116 Million JPY | -452.38% |
2022 Q3 | -21 Million JPY | -110.82% |
2022 Q2 | 194 Million JPY | 546.67% |
2021 Q4 | 49 Million JPY | -45.56% |
2021 Q1 | 35 Million JPY | -69.83% |
2021 Q2 | 142 Million JPY | 305.71% |
2021 Q3 | 90 Million JPY | -36.62% |
2021 FY | 316 Million JPY | -44.95% |
2020 Q1 | -5 Million JPY | -104.13% |
2020 Q2 | 401 Million JPY | 8120.0% |
2020 Q3 | 62 Million JPY | -84.54% |
2020 Q4 | 116 Million JPY | 87.1% |
2020 FY | 574 Million JPY | 399.13% |
2019 Q1 | -86 Million JPY | -160.61% |
2019 FY | 115 Million JPY | -39.47% |
2019 Q4 | 121 Million JPY | -33.52% |
2019 Q3 | 182 Million JPY | 278.43% |
2019 Q2 | -102 Million JPY | -18.6% |
2018 Q3 | 11 Million JPY | 10.0% |
2018 Q2 | 10 Million JPY | -75.61% |
2018 Q1 | 41 Million JPY | 165.08% |
2018 FY | 190 Million JPY | 27.52% |
2018 Q4 | -33 Million JPY | -400.0% |
2017 FY | 149 Million JPY | -78.95% |
2017 Q3 | 130 Million JPY | 195.45% |
2017 Q2 | 44 Million JPY | 15.79% |
2017 Q4 | -63 Million JPY | -148.46% |
2017 Q1 | 38 Million JPY | 1366.67% |
2016 Q3 | 178 Million JPY | -39.25% |
2016 Q4 | -3 Million JPY | -101.69% |
2016 FY | 708 Million JPY | 36.15% |
2016 Q1 | 240 Million JPY | 63.27% |
2016 Q2 | 293 Million JPY | 22.08% |
2015 Q2 | 150 Million JPY | -42.31% |
2015 FY | 520 Million JPY | 26.52% |
2015 Q4 | 147 Million JPY | 96.0% |
2015 Q1 | 260 Million JPY | 642.86% |
2015 Q3 | 75 Million JPY | -50.0% |
2014 FY | 410.99 Million JPY | -32.65% |
2014 Q2 | 28.85 Million JPY | -86.96% |
2014 Q1 | 221.3 Million JPY | 204.03% |
2014 Q4 | 35 Million JPY | -60.25% |
2014 Q3 | 88.04 Million JPY | 205.09% |
2013 Q4 | 72.78 Million JPY | -55.72% |
2013 FY | 610.27 Million JPY | 5.55% |
2013 Q3 | 164.39 Million JPY | 18.15% |
2013 Q2 | 139.14 Million JPY | -38.22% |
2013 Q1 | 225.23 Million JPY | 176.34% |
2012 Q1 | 222.47 Million JPY | 204.6% |
2012 FY | 578.19 Million JPY | 2.44% |
2012 Q4 | 81.5 Million JPY | -38.57% |
2012 Q3 | 132.67 Million JPY | -11.56% |
2012 Q2 | 150 Million JPY | -32.58% |
2011 FY | 564.42 Million JPY | 0.0% |
2011 Q2 | 127.49 Million JPY | -32.47% |
2011 Q3 | 103.12 Million JPY | -19.11% |
2011 Q4 | 73.03 Million JPY | -29.18% |
2011 Q1 | 188.8 Million JPY | 30.2% |
2010 Q1 | 191.05 Million JPY | 204.7% |
2010 FY | - JPY | -100.0% |
2010 Q4 | 145 Million JPY | 0.0% |
2010 Q2 | 107.16 Million JPY | -43.91% |
2009 Q1 | 115.47 Million JPY | -6.24% |
2009 Q2 | 105.24 Million JPY | -8.85% |
2009 Q3 | -6.41 Million JPY | -106.09% |
2009 FY | 337.46 Million JPY | 149.46% |
2009 Q4 | 62.7 Million JPY | 1078.04% |
2008 Q3 | -49.4 Million JPY | -316.71% |
2008 Q1 | 131.76 Million JPY | 0.0% |
2008 FY | 135.27 Million JPY | -69.78% |
2008 Q2 | 22.79 Million JPY | -82.7% |
2008 Q4 | 123.15 Million JPY | 349.28% |
2007 FY | 447.59 Million JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
HEARTSEED INC | -1.47 Billion JPY | 131.897% |
Cawachi Limited | 4.71 Billion JPY | 90.028% |
Pharmarise Holdings Corporation | -351 Million JPY | 233.903% |
Qol Holdings Co., Ltd. | 4.88 Billion JPY | 90.369% |
MatsukiyoCocokara & Co. | 52.34 Billion JPY | 99.102% |
Welcia Holdings Co., Ltd. | 26.45 Billion JPY | 98.223% |
Create SD Holdings Co., Ltd. | 13.69 Billion JPY | 96.567% |
NIHON CHOUZAI Co.,Ltd. | 2.55 Billion JPY | 81.59% |
COSMOS Pharmaceutical Corporation | 24.45 Billion JPY | 98.078% |
Tsuruha Holdings Inc. | 24.1 Billion JPY | 98.05% |
Ohki Healthcare Holdings Co.,Ltd. | 2.21 Billion JPY | 78.733% |
Kusuri No Aoki Holdings Co., Ltd. | 12.3 Billion JPY | 96.181% |
Medical System Network Co., Ltd. | 1.86 Billion JPY | 74.731% |
Shinnihonseiyaku Co., Ltd. | 2.39 Billion JPY | 80.368% |
Sugi Holdings Co.,Ltd. | 21.97 Billion JPY | 97.862% |
YAKUODO HOLDINGS Co., Ltd. | 3.82 Billion JPY | 87.712% |
Astena Holdings Co., Ltd. | 1.16 Billion JPY | 59.578% |
Genky DrugStores Co., Ltd. | 6.32 Billion JPY | 92.568% |
Ain Holdings Inc. | 11.4 Billion JPY | 95.878% |
Sundrug Co.,Ltd. | 29.12 Billion JPY | 98.386% |